Early research (Phase 1)Study completedNCT01976741What this trial is testingDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)Who this might be right forNeoplasms Bayer 168
Testing effectiveness (Phase 2)Study completedNCT03430895What this trial is testingEvaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary TractWho this might be right forNon-Transitional Cell Carcinoma of the Urothelial TractSmall Cell of the BladderAdenocarcinoma of the Bladder+2 more Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT04424641What this trial is testingA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more Genmab 48
Early research (Phase 1)UnknownNCT04660929What this trial is testingCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsWho this might be right forHER2-positiveAdenocarcinomaBile Duct Cancer+28 more Carisma Therapeutics Inc 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Early research (Phase 1)Active Not RecruitingNCT03983954What this trial is testingNaptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Who this might be right forER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more NeoTX Therapeutics Ltd. 120
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT05077709What this trial is testingIO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBCWho this might be right forLung Cancer Non Small CellHead and Neck Squamous Cell CarcinomaUrothelial Carcinoma Bladder IO Biotech 63
Testing effectiveness (Phase 2)Study completedNCT02001623What this trial is testingTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvary CancerCervix CancerEndometrium Cancer+5 more Seagen Inc. 195
Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Looking for participantsNCT06022029What this trial is testingA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.Who this might be right forTriple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more OncoNano Medicine, Inc. 168
Early research (Phase 1)Study completedNCT03229278What this trial is testingTrigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaWho this might be right forLymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Ended earlyNCT00112905What this trial is testingSorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumWho this might be right forAdenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more National Cancer Institute (NCI) 27
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT00006026What this trial is testingNitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 21